Investing

Carl Icahn Goes After Biogen Idec (BIIB)

Biogen_logoBiogen Idec (NASDAQ: BIIB) is coming under fire from activist investor Carl Icahn this morning.  A release came out as a "shareholder proposal" from Icahn Partners LP.  He is asking for four positions for new board members, as well as jurisdiction changes.

Icahn and certain affiliates are proposing the nomination of fourindividuals to serve on the board of directors of the company at theannual meeting:

  • Alexander J. Denner,
  • Richard C. Mulligan,
  • Thomas J. Deuel,
  • and David Sidransky

The proposal also seeks to request that the board changes its companyjurisdiction of incorporation to North Dakota and to amend the bylawsto set the size of the Board at 13.

Biogen Idec’s Board will review the notice and consider it in light ofthe best interests of all shareholders of the Company….

Jon C. Ogg
February 6, 2009

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans  set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?

Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.

Why wait? Click here to get started today!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.